Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:KNTE

Kinnate Biopharma (KNTE) Stock Price, News & Analysis

Kinnate Biopharma logo

About Kinnate Biopharma Stock (NASDAQ:KNTE)

Advanced Chart

Key Stats

Today's Range
$2.65
$2.65
50-Day Range
$2.45
$2.66
52-Week Range
$1.04
$7.18
Volume
N/A
Average Volume
418,678 shs
Market Capitalization
$125.13 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive KNTE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Kinnate Biopharma and its competitors with MarketBeat's FREE daily newsletter.

KNTE Stock News Headlines

Kinetic Engineering Ltd (KNTE)
KNTE Kinnate Biopharma Inc.
Everyone’s watching Nvidia right now. Here’s why I’m excited.
So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal with Saudi Arabia to power its new AI empire 🤯 We’re talking about hundreds of thousands of chips, including their latest Grace Blackwell supercomputer.
See More Headlines

KNTE Stock Analysis - Frequently Asked Questions

Kinnate Biopharma Inc. (NASDAQ:KNTE) posted its quarterly earnings data on Thursday, May, 11th. The company reported ($0.73) earnings per share (EPS) for the quarter, hitting the consensus estimate of ($0.73).

Kinnate Biopharma (KNTE) raised $170 million in an initial public offering on Thursday, December 3rd 2020. The company issued 10,000,000 shares at a price of $16.00-$18.00 per share. Goldman Sachs, SVB Leerink, Piper Sandler and Wedbush PacGrow acted as the underwriters for the IPO.

Based on aggregate information from My MarketBeat watchlists, some other companies that Kinnate Biopharma investors own include NVIDIA (NVDA), Alibaba Group (BABA), Advanced Micro Devices (AMD), Meta Platforms (META), Canopy Growth (CGC) and DraftKings (DKNG).

Company Calendar

Last Earnings
5/11/2023
Today
7/13/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
NASDAQ:KNTE
CIK
1797768
Fax
N/A
Employees
84
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($2.78)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$116.27 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-62.31%
Return on Assets
-54.72%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
10.80
Quick Ratio
10.80

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$5.06 per share
Price / Book
0.52

Miscellaneous

Outstanding Shares
47,220,000
Free Float
27,532,000
Market Cap
$125.13 million
Optionable
Optionable
Beta
1.38
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

This page (NASDAQ:KNTE) was last updated on 7/13/2025 by MarketBeat.com Staff
From Our Partners